Dr. Gunnar Riemann
Member of the Executive Board
Dr. Gunnar Riemann is Member of the Board of Management of Bayer Schering Pharma AG. Within the combined pharmaceutical businesses of Bayer und Schering, he is in charge of the Oncology, Hematology and Cardiology, Dermatology and Specialty Therapeutics business units and also responsible for the regions Latin and North America. Dr. Riemann was appointed President of the Pharmaceuticals Division at Bayer on March 1, 2006, and has been a member of Bayer HealthCare’s Executive Committee since mid-July 2002. He has also been a member of the Board of Management of Bayer HealthCare AG since 2004.
Career
Dr. Riemann was born in Hameln, Germany, on October 26, 1958. He studied pharmacy at Braunschweig Technical University where he obtained his Ph.D. in biochemistry with a doctorate written at the German Research Center for Biotechnology. Dr. Riemann started his career at Bayer in 1986 in the Health Care Sector’s Institute for Pharmaceutical Technology in Leverkusen, Germany. He was manager of a pharmaceuticals production plant from 1987 to 1991. From 1991 to 1994 he headed product development for OTC products at the Bayer subsidiary Miles Inc., Elkhart, Indiana, USA.
Dr. Riemann then returned to Leverkusen to head the Household Products Business Unit in the Consumer Care Business Group. In 1996 he took charge of the Asia/South America region and from 1999 to September 2001 he was in charge of the Consumer Care Business Group’s activities in Europe. He was subsequently appointed President of the Biological Products Business Group, headquartered in Research Triangle Park, North Carolina (USA). Dr. Riemann was also Executive Vice President and a member of the Executive Committee of Bayer Corporation. In January 2004 he was appointed President of the Animal Health Division.
